Marex CEO Buys Shares
Ticker: MRX · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1997464
| Field | Detail |
|---|---|
| Company | Marex Group PLC (MRX) |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-buy, ceo-purchase, 6-k
TL;DR
Marex CEO just bought shares, signaling confidence.
AI Summary
On October 13, 2025, Marex Group plc announced that its Chief Executive Officer purchased ordinary shares. The company is a global financial services firm specializing in the execution, clearing, and financing of exchange traded derivatives and securities. This filing is a Form 6-K report for the month of October 2025.
Why It Matters
A CEO purchasing company shares can signal confidence in the company's future prospects, potentially influencing investor sentiment.
Risk Assessment
Risk Level: low — This filing is a routine report of a CEO share purchase and does not indicate significant new risks.
Key Players & Entities
- Marex Group plc (company) — Registrant
- Chief Executive Officer (person) — Purchaser of shares
- October 13, 2025 (date) — Date of press release and share purchase announcement
- 155 Bishopsgate London EC2M 3TQ (location) — Company's UK address
FAQ
What type of shares did the CEO purchase?
The filing states the CEO purchased 'ordinary shares'.
When was the press release announcing the CEO's share purchase issued?
The press release was issued on October 13, 2025.
What is the primary business of Marex Group plc?
Marex Group plc is a global financial services firm specializing in the execution, clearing, and financing of exchange traded derivatives and securities.
What is the filing number for Marex Group plc?
The Commission File Number for Marex Group plc is 001-42020.
Does Marex Group plc file annual reports under Form 20-F or 40-F?
Marex Group plc files annual reports under Form 20-F.
Filing Stats: 227 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2025-10-14 08:08:22
Filing Documents
- d81338d6k.htm (6-K) — 10KB
- d81338dex991.htm (EX-99.1) — 3KB
- 0001193125-25-238153.txt ( ) — 15KB
From the Filing
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-42020 MAREX GROUP PLC (Translation of registrant's name into English) 155 Bishopsgate London EC2M 3TQ United Kingdom +44 20 7655 6000 140 East 45th Street, 10th Floor New York, New York 10017 (212) 618-2800 (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-FForm 40-F EXPLANATORY NOTE Purchase of Ordinary Shares by Chief Executive Officer On October 13, 2025, Marex Group plc (the "Company") issued a press release titled "Marex announces purchase of shares by Chief Executive Officer". A copy of the press release is furnished as Exhibit 99.1 herewith. EXHIBIT INDEX The following exhibit is furnished as part of this Form 6-K: Exhibit No. Description 99.1 Press release dated October 13, 2025 titled "Marex announces purchase of shares by Chief Executive Officer" SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Marex Group plc Date: October 14, 2025 By: /s/ Robert Irvin Robert Irvin Chief Financial Officer